trending Market Intelligence /marketintelligence/en/news-insights/trending/wq7yi1jqzguvnrvhoi35ga2 content esgSubNav
In This List

Hoya fiscal Q4 earnings up 2.4% YOY

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Hoya fiscal Q4 earnings up 2.4% YOY

Tokyo-based Hoya Corp. said fiscal fourth-quarter profit rose 2.4% year over year while revenue rose 7.6%.

The Japanese healthcare supplies company's three-month profit attributable to owners of the company amounted to ¥19.37 billion, up from ¥18.92 billion in 2017.

Diluted EPS for the quarter was ¥50.90, up from ¥48.65 in the year-ago quarter.

Consolidated revenue for the three-month period ended March 31 came in at ¥135.92 billion, up from ¥126.30 billion the previous year.

Fourth-quarter research and development expenses were ¥5.91 billion, up from ¥5.70 billion in the year-ago period.

Full-year results

For the fiscal year ended March 31, Hoya said profit attributable to owners of the company was ¥99.49 billion, up 14.7% from ¥86.74 billion the previous year.

Diluted EPS was ¥257.88, up from ¥221.49 in the year-ago period.

Consolidated revenue for the 12-month period was ¥535.61 billion, up 11.8% from ¥478.93 billion in 2017. Research and development expenses for the full fiscal year reached ¥23.29 billion, up from ¥21.83 billion the previous year.

As of May 9, US$1 was equivalent to ¥109.74.